Overnutrition is associated with chronic inflammation in metabolic tissues. Whether metabolic inflammation compromises the neural regulatory systems and therefore promotes overnutrition-associated diseases remains unexplored. Here we show that a mediator of metabolic inflammation, IKKb/NF-kB, normally remains inactive although enriched in hypothalamic neurons. Overnutrition atypically activates hypothalamic IKKb/NF-kB at least in part through elevated endoplasmic reticulum stress in the hypothalamus. While forced activation of hypothalamic IKKb/ NF-kB interrupts central insulin/leptin signaling and actions, site-or cell-specific suppression of IKKb either broadly across the brain or locally within the mediobasal hypothalamus, or specifically in hypothalamic AGRP neurons significantly protects against obesity and glucose intolerance. The molecular mechanisms involved include regulation by IKKb/NF-kB of SOCS3, a core inhibitor of insulin and leptin signaling. Our results show that the hypothalamic IKKb/NF-kB program is a general neural mechanism for energy imbalance underlying obesity and suggest that suppressing hypothalamic IKKb/ NF-kB may represent a strategy to combat obesity and related diseases.
INTRODUCTION
The hypothalamus is the ''headquarters'' for regulating energy homeostasis (Elmquist and Flier, 2004; Schwartz and Porte, 2005) . This regulation is primarily mediated in the mediobasal hypothalamus (MBH) by orexigenic AGRP neurons that coexpress two neuropeptides-NPY (neuropeptide Y) and AGRP (agoutirelated protein)-and anorexigenic POMC neurons that coexpress two other neuropeptides-CART (cocaine-and amphetamine-regulated transcript) and POMC (proopiomelanocortin). Leptin and insulin work in these neurons to control these neuropeptides, leading to normal energy balance and the prevention of obesity. Research has revealed that insulin signaling and leptin signaling in the hypothalamus are integrated through at least PI-3K (Morton et al., 2005; Xu et al., 2005) , FoxO1 (Kim et al., 2006; Kitamura et al., 2006) , and mTOR (Cota et al., 2006) . Recent studies have also identified two common inhibitors for insulin and leptin signaling, SOCS3 and PTP1B (Bence et al., 2006) , but their significance in causing disease is poorly understood.
Loss of leptin or insulin signaling in the hypothalamus is sufficient to induce or promote obesity and type 2 diabetes (T2D), as clearly demonstrated in various genetic mouse models with neuronal ablation of insulin signaling (Bruning et al., 2000; Burks et al., 2000; Obici et al., 2002) or leptin signaling (Balthasar et al., 2004; Bates et al., 2003; Lee et al., 1996) . In obesity and T2D, along with striking hyperinsulinemia and hyperleptinemia, insulin and leptin levels in the cerebrospinal fluid are elevated, all of which indicate a chronic state of central insulin and leptin resistance. Central administration of insulin or leptin consistently compromises the ability to control food intake in animals during the development of dietary obesity, confirming that hypothalamic (or central) leptin and insulin resistance contribute to the pathophysiology of obesity and T2D. Recent research has also dissociated overnutrition from obesity, demonstrating that overnutrition directly blunts central insulin and leptin sensitivity before the onset of obesity (Wang et al., 2001; Woods et al., 2004) . However, how central insulin and leptin resistance are induced by overnutrition and whether core mechanism(s) might be involved are both currently unknown.
IKKb/NF-kB is a master switch and central regulator of innate immunity and related functions (Hayden and Ghosh, 2008) . In the quiescent state, NF-kB remains inactive in the cytoplasm through binding to the inhibitory protein IkB. Activation of IKKb by phosphorylation at S177 and S181 induces phosphorylation of its substrate IkBa at S32 and S36, ubiqitination, and subsequent proteosomal degradation. The disappearance of IkBa releases NF-kB to translocate into the nucleus where it mediates the transcription of its target genes. Research during recent decades recognized that overnutrition can induce inflammatory responses in the peripheral metabolic tissues (metabolic inflammation) and therefore cause various metabolic defects in those tissues that underlie T2D (Hotamisligil, 2006; Lehrke and Lazar, 2004) . In this context, IKKb was identified as a target for an anti-inflammatory therapy that was effective for obesityassociated T2D (Yuan et al., 2001 ). Subsequently, a series of discoveries revealed that IKKb/NF-kB located in peripheral metabolic tissues affects glucose and protein metabolism in tissue-specific manners (Arkan et al., 2005; Cai et al., 2004 Cai et al., , 2005 . However, it still remains unexplored whether metabolic inflammation and related mediators could target the metabolic regulatory pathways in the central nervous system (CNS), thus leading to a family of diseases related to overnutrition and obe- (D) DNA-binding activity of NF-kB and an irrelevant control (Sp1) was measured using EMSA in the hypothalamus from HFD-versus chow-fed C57BL/6 mice. Cold competition (C) with 200-fold excess of unlabeled NF-kB oligo and mutant NF-kB probe (M) was used to assess the specificity of the NF-kB EMSA blots. N: nonspecific protein (BSA). (E and F) NF-kB-induced luciferase activity was measured in the hypothalamus harvested from the NF-kB reporter mice that received intra-third ventricle infusion of 6 mg glucose (E) or 40 mg oleic acid (F) over 6 hr. The controls (Con) represent the infusion of the empty vehicle or the same concentrations of sorbitol (n = 4-5 per group, *p < 0.05). 3V: third ventricle. Error bars reflect mean ± SEM. sity. In this study, we explored whether IKKb/NF-kB is the fundamental connection between overnutrition and the dysfunctions of hypothalamic signaling that cause obesity and associated problems.
RESULTS

IKKb/NF-kB Is Enriched but Suppressed in the Hypothalamus
Obesity and associated diseases are characterized by a chronic state of metabolic inflammation. We investigated a possible connection between IKKb/NF-kB and the central dysregulation of energy balance in the hypothalamus. First, we dissected the hypothalamus (Figure S1A available online) and the peripheral organs in normal mice and observed that the IKKb protein was highly enriched in the hypothalamus ( Figure 1A ). For comparison, IKKa, an IKK isoform that has different signaling and functions from the IKKb/NF-kB axis, is present at similar levels in the hypothalamus and many of the peripheral tissues ( Figure 1A ). Using in situ hybridization, we revealed that IKKb is expressed predominantly in the MBH ( Figure 1B ). After confirming the specificity of IKKb immunostaining ( Figures S2 and S3 ), we revealed that IKKb is stained in the neurons but is barely stained in nonneuronal cells (such as astrocytes) in the MBH ( Figure 1C ). Thus, IKKb possesses a unique, distinct pattern in the hypothalamus.
When IKKb is inactive, its substrate IkBa remains intact, which specifically binds to and inhibits NF-kB. We noted that the levels of IkBa were normally high in the hypothalamus relative to the levels in the peripheral tissues ( Figure 1A ), indicating that both IKKb and NF-kB are suppressed in the hypothalamus in normal physiology with standard nutrition. EMSA further indicated that hypothalamic NF-kB activity was relatively low in normal mice fed standard chow ( Figure 1D ). The super-shift results confirmed that hypothalamic NF-kB is the canonical complex composed of p65 (RelA) and p50 ( Figure S4A ). We also employed NF-kB reporter mice (Everhart et al., 2006) , which report NF-kB activity through the NF-kBcontrolled expression of an eGFP-Luciferase fusion protein (NGL mice). We confirmed that hypothalamic NF-kB activity was normally modest by measuring either luciferase activity ( Figure S5A ) or eGFP expression ( Figure S5B ) in the hypothalamus. In sum, IKKb/NF-kB remains suppressed although enriched in the hypothalamus under conditions where nutrition is normal.
Hypothalamic IKKb/NF-kB Is Activated by Overnutrition
We then explored whether IKKb/NF-kB in the hypothalamus might be affected by overnutrition, a condition that causes obesity and metabolic inflammation. We observed that a chronic high-fat diet (HFD) feeding upactivated NF-kB in the hypothalamus by $2-fold ( Figure 1D ). NF-kB activity was 5-to 6-fold higher in the hypothalamus of ob +/+ mice (a hyperphagic obesity), even when fed normal chow, than in the controls (WT mice) ( Figure S4B ). We then used the NGL mice to examine the MBH, the predominant region that expresses IKKb. In contrast to the low levels of eGFP expression when the NGL mice were fed a normal chow, a HFD clearly induced eGFP expression in the MBH neurons of the NGL mice ( Figures S5B and S5C) . Thus, the MBH, the first-order brain region for nutrition sensing, represents an important hypothalamic site for the activation of NF-kB through overnutrition. In addition, we observed that mRNA levels of IKKb and IkBa in the hypothalamus increased both in C57BL/6 mice fed a HFD and in ob +/+ mice fed a normal chow ( Figure S6 ). These observations further support our understanding that IKKb/NF-kB is upactivated in the hypothalamus by chronic overnutrition. We then explored whether the effect of overnutrition on hypothalamic IKKb/NF-kB could be dissected from obesity. NGL mice fasted overnight received a 6 hr infusion of 20% glucose at the rate of 5 ml/hr through cannula implanted in the third ventricle. The glucose infusion increased the hypothalamic glucose content, which reached 80% of the levels seen in obese and diabetic db/db mice ( Figure S7 ). Through measuring NF-kB-driven luciferase activities, we found that the acute overload of glucose significantly increased the NF-kB activity in the hypothalamus ( Figure 1E ) but not in the peripheral tissues. We also performed an intra-third ventricle infusion of another nutrient species, oleic acid (OA), using the method and doses established in the recent literature (Lam et al., 2005) . OA infusion increased the hypothalamic NF-kB activity in the NF-kB reporter mice ( Figure 1F ) in much the same way as did the glucose infusion. These experiments and results indicate that oversupply of general nutrients can acutely activate hypothalamic IKKb/NF-kB before the onset of obesity. On the other hand, we noted that a physiological supply of nutrients, such as refeeding following a period of fasting, did not evidently affect hypothalamic NF-kB activity, suggesting that activation of IKKb/NF-kB is not physiologically required. Our results suggest that chronic overnutrition most likely provides repetitive and persistent signals that upregulate IKKb/NF-kB in the hypothalamus.
We then determined whether inflammatory molecules, like those driven by NF-kB typically in immune cells, might be overproduced in the hypothalamus of obese mice. Quantitative RT-PCR revealed normal mRNA levels in the hypothalamus of either HFD-fed C57BL/6 mice or normal chow-fed ob +/+ mice for almost all the cytokines and their receptors that we examined (Table S1 ). In contrast, quantitative RT-PCR revealed markedly elevated mRNA levels in the NF-kB signaling components, including IKKb and IkBa, in the hypothalamus ( Figure S6 ). Consistent with recent literature (Munzberg and Myers, 2005) , SOCS3 mRNA levels in the hypothalamus of HFD-treated mice and normal chow-fed ob +/+ mice were both moderately increased. We therefore suggest that the neuronal activation of IKKb/NF-kB in the hypothalamus by overnutrition leads to neuron-specific responses mostly associated with noncytokine program(s).
Targeting IKKb/NF-kB in the Hypothalamus and in the Brain to Control Obesity We previously reported that constitutively active IKKb (IKKb CA ) mimics IKKb phosphorylation, leading to chronic activation of NF-kB (Cai et al., 2004 (Cai et al., , 2005 . Here, we first cloned IKKb CA into a lentiviral vector, in which the synapsin promoter controls the neuron-specific expression of Flag-tagged IKKb CA . In parallel, we also cloned dominant-negative (inhibitory) IKKb (IKKb  DN ) into the same viral vector. The same lentiviral vector containing GFP was used as the control. Using the technique of MBHdirected injections (Figures S1B, and S1C), we delivered each lentivirus bilaterally into the MBH of HFD-fed C57BL/6 mice. While no anatomic lesions were caused, site-specific expression of the targets was confirmed by immunostaining of IKKb-conjugated Flag tag ( Figure 2A) . With low-level but persistent exogenous activation of IKKb/NF-kB in the MBH by expressed IKKb CA , HFD intake and weight gain of the mice were significantly although mildly promoted ( Figures 2B and 2C ). Conversely, delivery of IKKb DN in the MBH neurons reduced the levels of HFD-induced weight gain by restricting HFD intake ( Figures 2B and 2C ). Considering the disadvantages of a viral approach, such as random infections and immunogenicity of viral particles, we further employed mouse models with genetic suppression of IKKb in the brain. We first crossed IKKb lox/lox mice (Arkan et al., 2005) with a line of brain-specific Cre transgenic mice, Nestin-Cre mice; both lines had the C57BL/6 background. The compound offspring, Nestin/IKKb lox/lox mice, contained brain-specific ablation of IKKb ( Figure 2D) month to initiate dietary obesity, and following the injections, we continued to treat both mouse groups with the HFD. Using this protocol, we observed that the HFD increased body weight to a much lesser degree in the MBH-Cre/IKKb lox/lox mice than in the control mice ( Figure 2G ). Consistently, the MBH-IKKb lox/lox mice consumed less HFD than did the controls ( Figure 2H ). These re- per group, *p < 0.05, **p < 0.01).
(G and H) Body weight gain (G) and HFD intake (H) were measured in IKKb lox/lox mice that received MBH injections of Cre-or GFP-adenovirus (n = 11-13 per group, *p < 0.05, **p < 0.01). Error bars reflect mean ± SEM (B, C, and E-H).
sults further support that suppression of IKKb/NF-kB in the MBH offers resistance to obesity under conditions of overnutrition.
The Connection of Hypothalamic IKKb/NF-kB with Overnutrition by ER Stress
We then explored the intracellular components that could mediate nutritional activation of IKKb/NF-kB in the hypothalamus and subsequently cause diseases. Recently, ER (endoplasmic reticulum) stress was identified as a critical intracellular event that induces metabolic diseases under conditions of overnutrition (Ozcan et al., 2004 (Ozcan et al., , 2006 . We asked whether ER stress might be involved in the pathways that mediate nutritional activation of hypothalamic IKKb/NF-kB, and then disease. We first found that ER stress in the hypothalamus, quantitated by the phosphorylation levels of PERK, could be evidently induced by a HFD ( Figure 3A) , along with the HFD induction of NF-kB activation in the hypothalamus ( Figure 1D ). Furthermore, we revealed that the activation of hypothalamic NF-kB by a HFD was suppressed by an acute intra-third ventricle infusion of an ER stress inhibitor, tauroursodeoxycholic acid (TUDCA) ( Figures  3A and 3B ). In addition, we treated normal chow-fed C57BL/ 6 mice by an acute intra-third ventricle administration of an ER stress inducer, tunicamycin (TM). Our results revealed that TM activated hypothalamic NF-kB, while it remarkably promoted ER stress in the hypothalamus ( Figures 3C and 3D ). Thus, ER stress is an intracellular mediator of hypothalamic IKKb/NF-kB activation by overnutrition.
We further employed our lentiviral approach and mouse model to dissect the relationship between ER stress and IKKb/NF-kB in the hypothalamus. Using intrahypothalamic injections of IKKb CA lentivirus, we found that activating IKKb/NF-kB elevated ER stress in the hypothalamus, which was reflected by increased levels of both PERK and eIF2a phosphorylation ( Figure 3E ). This result indicates that ER stress is both an upstream mediator and a downstream event of IKKb/NF-kB activation in the hypothalamus. This claim was further supported by our findings demonstrating that HFD failed to induce ER stress in the hypothalamus of the Nestin/IKKb lox/lox mice ( Figure 3F ). Based on the dual roles of ER stress in the pathological cascade of hypothalamic IKKb/NF-kB, we assessed the potential disease relevance of ER stress in the CNS. To do this, we provided a chronic intra-third ventricle treatment of TUDCA for mice with obesity induced by a HFD. We found that while the TUDCA treatment did not cause obvious side effects, it significantly decreased the degree of obesity ( Figure 3G ), which was associated with the re-balance of food intake in these mice ( Figure 3H ). The an- (G and H) HFD-fed mice received daily intra-third ventricle injections of TUDCA (5 mg/day) or the empty vehicle (aCSF) for 10 days. The body weight (G) and average food intake (H) of these mice were measured before (day 0) and upon the completion of the 10 day therapy (n = 5 per group, *p < 0.05).
Error bars reflect mean ± SEM.
tiobesity benefits caused by suppressing ER stress in the CNS resemble the antiobesity effects from suppressing IKKb/ NF-kB in the CNS (Figure 2 ). Thus, under conditions of overnutrition, ER stress and IKKb/NF-kB in the hypothalamus enhance each other, leading to the central mechanisms of energy imbalance and disease.
Activating Hypothalamic IKKb/NF-kB Causes Central Insulin and Leptin Resistance
Insulin resistance can be caused in the peripheral tissues by either activating IKKb/NF-kB (Cai et al., 2005) or ER stress (Ozcan et al., 2004 (Ozcan et al., , 2006 . Since insulin signaling in the hypothalamus is also critical for the central regulation of food and weight balance, we examined whether IKKb/NF-kB interrupts central insulin signaling in the hypothalamus. We delivered IKKb CA bilaterally into the MBH of adult C57BL/6 mice using an adenoviral vector. As controls, we used the same viral vector in which IKKb CA was replaced by either GFP or IKKb DN . We observed that IKKb CA remarkably impaired Akt activation in response to a third ventricle injection of insulin, but Akt activation was not affected by either IKKb DN or GFP ( Figure 4A ). Tyrosine phosphorylation in IR and IRS2 and the binding of IRS2 to PI3 kinase subunit p85 were all suppressed by IKKb CA ( Figure S9 ), although the effects were somewhat milder. The inhibitory effects of IKKb CA on insulin signaling were also recapitulated in vitro in hypothalamic GT1-7 cells ( Figure S10 ). These results further reinforce the negative relationship between IKKb/NF-kB and hypothalamic insulin signaling.
We also employed immunostaining to directly examine the effects of IKKb CA on insulin signaling in the MBH. After having confirmed the specific immunostaining for insulin-induced PIP3 production in the MBH in overfasted mice ( Figure S11 ), we used adenovirus to deliver IKKb CA into one side of the MBH and GFP into the other side of the MBH in the same mice (Figure 4Ca ), which provided the best means of comparison. In response to a third-ventricle injection of insulin, PIP3 was normally induced in the MBH side with GFP; in contrast, very little PIP3 was induced in the MBH side with IKKb CA (Figure 4Cb ), indicating that IKKb CA caused severe insulin insensitivity in the MBH. Following these signaling analyses, we continued to evaluate whether a bilateral delivery of IKKb CA into the MBH was sufficient to affect the ability of central insulin administration to suppress food intake. We found that insulin decreased food intake induced by fasting in the control mice that expressed GFP in the MBH; in contrast, insulin failed to significantly decrease food intake induced by fasting in mice that expressed IKKb CA in the MBH ( Figure 4D ). Thus, from a functional standpoint, this result again suggests that local activation of IKKb/NF-kB in the MBH impairs hypothalamic insulin signaling. Recent research has established that insulin and leptin signaling function together in the hypothalamus to control energy balance. We explored whether activation of IKKb/NFkB in the MBH might also affect hypothalamic leptin signaling. We continued to employ the mouse models in which either IKKb CA or a control was bilaterally delivered into the MBH. Our western blots ( Figure 4B ) and immunostaining (Figures 4Cc-4Cd , S11C, and S11D) both revealed that leptin-induced STAT3 phosphorylation in the hypothalamus was reduced by IKKb CA in the MBH. Furthermore, we observed that while leptin reduced fasting-induced food intake by 50.0% in the control mice that expressed GFP bilaterally in the MBH, the reduction was only 26.5% in mice that expressed IKKb CA bilaterally in the MBH ( Figure 4E ). To summarize, IKKb/NF-kB activation in the MBH causes both central insulin and leptin resistance.
IKKb Ablation in Hypothalamic AGRP Neurons Controls Obesity
Because IKKb/NF-kB activation interrupts insulin and leptin signaling, we hypothesized that ablating IKKb in the insulin-and leptin-sensitive hypothalamic neurons might yield relevant metabolic effects. We targeted AGRP neurons, which are localized mainly in the MBH and are a critical source of hypothalamic insulin and leptin signaling. We bred IKKb lox/lox mice with AGRP-Cre mice in which Cre was located almost exclusively in the targeted MBH neurons (Xu et al., 2005) ( Figure S12 ). Our data verified the suitability of AGRP-Cre mice for this study by showing that AGRP-Cre mice, when fed either a chow or a HFD, consumed food and gained body weight similarly to wild-type mice ( Figures  S8C and S8D) . We refer to offspring with the AGRP neuron-specific knockout of IKKb (confirmed in Figure 5A by immunostaining) as AGRP/IKKb lox/lox mice. Littermate AGRP-Cre mice and IKKb lox/lox mice were used as controls. As noted previously (Xu et al., 2005) , a fraction of AGRP/IKKb lox/lox mice exhibited partial IKKb excision in the whole body due to occasional promoter leakage during the embryonic development; we identified these mice using a PCR method and excluded them from the studies. AGRP/IKKb lox/lox mice displayed normal offspring frequency, growth, and activity. When fed normal chow, the body weight and food intake of these mice resembled those of the control mice, including AGRP-Cre, IKKb lox/lox , and wild-type mice. Therefore, the AGRP/IKKb lox/lox mice represent a suitable model for studying the hypothalamic control of energy balance. We treated the AGRP/IKKb lox/lox mice and the matched controls with a HFD post-weaning. After 12 weeks of the HFD, the body weight of AGRP/IKKb lox/lox mice was 13.1% less than that of the controls ( Figure 5B ). On average, AGRP/IKKb lox/lox mice ate 10.2% less than the controls (Figure 5C ). The antiobesity phenotype of the AGRP/IKKb lox/lox mice almost reached the level of the Nestin/IKKb lox/lox mice (Figure 2 ), thus suggesting that AGRP neurons are mainly responsible for the neural effects of IKKb/NF-kB on body weight homeostasis.
We also assessed the antiobesity characteristics of the AGRP/ IKKb lox/lox mice from the aspects of obesity-associated glucose intolerance and central insulin/leptin resistance. HFD-fed AGRP/ IKKb lox/lox mice and the matched controls were fasted overnight and subjected to a glucose tolerance test (GTT). As expected, glucose tolerance was impaired in the control mice after 3 months of a HFD. In contrast, HFD failed to induce glucose intolerance in the AGRP/IKKb lox/lox mice ( Figure 5D ). We also assessed central insulin and leptin resistance as two biochemical markers of obesity. Compared to mice fed a normal chow, both insulin and leptin signaling were barely induced in the mice fed a HFD, indicating a state of central insulin and leptin resistance that was chronically induced by HFD. In contrast, both insulin and leptin signaling were significantly preserved in the hypothalamus of HFD-fed AGRP/IKKb lox/lox mice ( Figures 5E and 5F) in which only the AGRP neurons were targeted for IKKb ablation.
To further confirm that the metabolic phenotypes of AGRP/ IKKb lox/lox mice were hypothalamic, we used an adenovirus to bilaterally deliver either IKKb or control GFP into the MBH of AGRP/IKKb lox/lox mice that had been fed a HFD for 2 months.
As further controls, we used the same approach to deliver IKKb or GFP into the MBH of the littermate IKKb lox/lox mice that were also fed a HFD for 2 months. We observed that the protection against the induction of weight gain by a HFD in AGRP/ IKKb lox/lox mice was eliminated by restoring IKKb in the MBH ( Figure 5G ). To reflect such a phenotype reversal, intake of the HFD in AGRP/IKKb lox/lox mice nearly approached the levels displayed by IKKb lox/lox mice during the progression to obesity (Figure 5H ). In sum, the hypothalamic AGRP neurons are critical for the pathological action of IKKb/NF-kB in the central dysregulation of energy balance.
IKKb/NF-kB Promotes SOCS3 Expression
Our results led to the consideration of how IKKb/NF-kB causes hypothalamic insulin and leptin resistance. Recent research shows that SOCS3 is a critical inhibitor for both insulin and leptin signaling in the hypothalamus (Howard et al., 2004; Mori et al., 2004; Ueki et al., 2004) . Using luciferase driven by the mouse SOCS3 promoter in the pGL3 plasmid (SOCS3-pGL3), we tested whether NF-kB regulates the promoter activity of SOCS3 in cultured cells. This SOCS3 promoter contains two putative NF-kB-DNA binding motifs at À94 and À754 bp. Our results revealed that IKKb CA expression increased SOCS3 promoter activity ( Figure S13A ). This increase was abolished by expressing the IkBa super-repressor (IkBa SR ) ( Figure S13A ), which selectively inhibited NF-kB but not the upstream IKKb. In addition to the promoter assay, we also found that both mRNA and protein levels of SOCS3 were stimulated by TNF-a (an activator of IKKb/NF-kB) in HEK293 cells, and these effects were reversed by expressing IkBa SR in these cells ( Figures S14A and S14B ).
All these results indicate that IKKb/NF-kB possesses the ability to activate the SOCS3 gene. We then screened various stimuli that increase SOCS3 promoter activity in cultured cells and further tested whether addition of IkBa SR could inhibit the increase. In HEK293 cells stably expressing leptin receptor, leptin increased SOCS3 promoter activity, but interestingly, insulin also increased its activity ( Figure S13B ). Further, IkBa SR reduced the effects of leptin and insulin in stimulating the SOCS3 promoter activity (Figure S13B) . Therefore, SOCS3, classically produced by STAT3 that can be activated through leptin, is also controlled by NFkB. To further support this hypothesis, we deleted each of the two putative NF-kB-DNA binding motifs in the SOCS3-pGL3 plasmid. The activity of the SOCS3 promoter was substantially reduced by deleting either NF-kB-DNA binding motif ( Figure S13C ). These results further suggest that IKKb/NF-kB is involved in SOCS3 gene activation. In addition, using RT-PCR and western blot analyses ( Figures S14C and S14D) , we confirmed that a virus-mediated delivery of IKKb CA into the MBH significantly elevated SOCS3 mRNA and protein in the hypothalamus of mice fed a normal chow. The induction of SOCS3 by IKKb CA in the hypothalamus is relatively modest but nonetheless correlates with a similar increase of hypothalamic SOCS3 under conditions of overnutrition (Table S1 ). Further, the modest increase of SOCS3 is reminiscent of the ''low-grade levels'' of metabolic inflammation present in obesity and related diseases and could be pathogenically relevant to the development of these diseases.
SOCS3 Mediates the Effects of Hypothalamic IKKb/NF-kB on Energy Balance
Following our observation showing that a HFD failed to increase the hypothalamic levels of SOCS3 mRNA in Nestin-IKKb lox/lox mice ( Figure 6A ), we further examined whether the acute promotion of hypothalamic SOCS3 mRNA by leptin could be impaired by IKKb ablation. We tested this question using AGRP-IKKb lox/lox mice since we have demonstrated that the hypothalamic AGRP neurons are mainly responsible for the antiobesity effect created by IKKb ablation. Our results revealed that hypothalamic SOCS3 mRNA levels in the AGRP-IKKb lox/lox mice were elevated by leptin to lesser degrees than in the control mice ( Figure 6B ). These data suggest that SOCS3 might be involved in the hypothalamic IKKb/NF-kB's dysregulation of energy balance. Indeed, after confirming the specificity of SOCS3 immunostaining ( Figures S15 and S16) , we revealed that a HFD significantly induced SOCS3 in the MBH ( Figure 6C ). We also noted that the induction of SOCS3 in the MBH by overnutrition appeared to be limited to the neurons, which evidently differs from the massive induction of SOCS3 in many glial cells in response to third-ventricle injections of cytokines such as LIF ( Figure S16B ). The neuronal activation of SOCS3 by HFD aligns well with our model showing that IKKb/NF-kB possesses neuronal, noncytokine program(s) for mediating the dysregulation of energy balance during overnutrition. To further examine the role of SOCS3 in the pathogenic cascade of hypothalamic IKKb/NF-kB during overnutrition, we employed a rescue experiment to determine whether adding SOCS3 to the MBH neurons of AGRP-IKKb lox/lox mice could reduce the antiobesity phenotype in these mice. We created a SOCS3 lentivirus controlled by a neuron-specific (synapsin) promoter. For the controls, we used the same lentivirus but with SOCS3 replaced by GFP. Following the intra-MBH injections of lentiviruses ( Figure 6D ), the mice were maintained on a HFD. Our study revealed that the exogenous expression of SOCS3 in the MBH neurons significantly decreased the antiobesity and feeding phenotypes of AGRPIKKb lox/lox mice ( Figures 6E and 6F) . Therefore, from a mechanistic point, these results further support our hypothesis that suppressing IKKb/NF-kB in hypothalamic neurons represents a promising strategy for counteracting obesity and associated diseases during overnutrition.
DISCUSSION
Overnutrition Subverts the Innate Immune Response of Hypothalamic IKKb/NF-kB Obesity and its co-morbidities represent one of the greatest epidemic and public health problems facing our society. Relatively recent environmental changes, especially overnutrition, are clearly responsible for the high prevalence of these diseases. Faced with the energy abundance typical of today's developed world, our control systems have yet to evolve to readily regulate the body's energy balance. This newly emerged challenge to the control systems in our bodies has led to excessive energy stores (fat) and ultimately to disease. While the CNS control systems, like the hypothalamus, might conceivably be essential for this regulatory failure, the participating molecular program(s) remain unknown. Our work shows that the ''master switch'' innate immunity regulator, IKKb/NF-kB, while highly enriched in the hypothalamic neurons is normally not activated. Importantly, this pathway can be activated in the hypothalamic neurons by the chronic overnutrition that causes obesity. Such activation can even be mimicked without obesity by an acute but extreme oversupply of various nutrients to the CNS. Our findings indicate that persistent signals to the CNS under conditions of overnutrition can atypically stimulate an innate immunitylike response directed by IKKb/NF-kB in the hypothalamic neurons; this process affects the neuronal regulation of energy balance (Figure 7) . Overall, our findings align with the emerging view that evolution integrated some regulatory pathways that govern the body's reactions to both pathogens and nutrition (Hotamisligil, 2006) . We postulate that the hypothalamus might have developed the unique property of responding to extreme environmental stimuli (previously pathogens, now overnutrition) by using IKKb/NF-kB to affect vital systems. Thus, although the near-instantaneous signaling of hypothalamic IKKb/NF-kB might once have been critical for survival in a pathogen-filled environment by helping innate immunity (an energy-intensive process), this signaling-as our study demonstrates-might now be very responsive and truly detrimental in today's near-constant calorie-rich environment. Hypothalamic IKKb/NF-kB could underlie the entire family of modern diseases induced by overnutrition and obesity.
The Hypothalamus as a Key Target for Metabolic Inflammation via IKKb/NF-kB Obesity and its associated diseases are characterized by chronic metabolic inflammation (Hotamisligil, 2006; Lehrke and Lazar, 2004) . This type of inflammation has been considered peripheral and a consequence of obesity. Our previous research established that IKKb/NF-kB promotes metabolic inflammation in peripheral tissues (Cai et al., 2004 (Cai et al., , 2005 . In this study, our research originated in an exploration of the potential metabolic relevance of the proinflammatory master switch IKKb/NF-kB in the hypothalamus. We discovered that IKKb/NF-kB in the hypothalamic neurons responds to the metabolic signals produced by overnutrition and is a general cause of multiple neural disease pathways and thus contributes to diseases related to overnutrition. Therefore, while obesity induces metabolic inflammation, our discovery indicates that metabolic inflammation could also promote energy imbalance and obesity by interrupting regulatory signaling in the CNS. It is also noteworthy that the hypothalamic dysregulation of energy balance by overnutrition involves a neuron-specific, noncytokine program through IKKb/NF-kB. This program significantly differs from the inflammatory reactions seen in the CNS of certain chronic, cachectic diseases (such as cancer, AIDS, and infectious diseases) that are often associated with chaotic releases and powerful actions of many inflammatory cytokines in nonneuronal cells, such as astrocytes, oligodendrocytes, and microglial cells.
A relevant question therefore concerns how overnutrition activates IKKb/NF-kB in the hypothalamus. We demonstrated that an acute, local oversupply of either glucose or lipid in the CNS recapitulated the hypothalamic activation of IKKb/NF-kB by chronic overnutrition. This separation of chronic overnutrition from obesity suggests that overnutrition might at least primarily activate IKKb/NF-kB in the hypothalamus. The effects of the individual nutrient species in the hypothalamus agree with many other studies showing that both glucose and lipid can activate IKKb/NF-kB in the peripheral metabolic tissues and cultured cells. A recent report found that Toll-like receptor 4 (TLR4) mediates lipid-induced insulin resistance (Shi et al., 2006) . Since TLR4 is an activator of IKKb/NF-kB in various circumstances (Hayden and Ghosh, 2008) , TLR4 could be a link between overnutrition and IKKb/NF-kB activation at the cell membrane level, but whether this potential relationship occurs in the hypothalamus remains to be explored. In this study, we show that ER stress and IKKb/NF-kB promote each other in the hypothalamus during overnutrition. This finding indicates that overnutrition could activate IKKb/NF-kB at the intracellular level in the hypothalamic neurons. Overall, this profile of hypothalamic IKKb/NF-kB reinforces recent research in which ER stress was implicated in metabolic inflammation (Hotamisligil, 2006) . Furthermore, in addition to the primary induction of hypothalamic IKKb/NF-kB by enriched nutrients, we postulate that the pathophysiological changes during the progress of obesity and T2D, such as hyperlipidemia, hyperglycemia, hyperinsulinemia, hyperleptinemia, and elevated inflammatory substances in the peripheral tissues and circulation, might secondarily, but significantly, promote ER stress and IKKb/NF-kB in the hypothalamus and accelerate disease progression (Figure 7 ).
IKKb/NF-kB: A Core Mechanism for Hypothalamic Insulin and Leptin Resistance Insulin and leptin signaling in the hypothalamus are critical for sensing the availability of fuel in the body and preventing excessive energy stores, and thus obesity. Recent research discovered that insulin and leptin signaling are integrated and function together to regulate energy balance. The PI-3K/Akt, FoxO1, MAP kinase, and mTOR pathways have recently been identified as molecular links between insulin and leptin signaling. Recent research has also demonstrated that overnutrition induces hypothalamic insulin and leptin resistance, but the underlying basis remains unknown. In this research, we discovered that IKKb/ NF-kB in the hypothalamus mediates both hypothalamic insulin and leptin resistance. Thus, our findings posit IKKb/NF-kB as a core disease pathway that mediates hypothalamic insulin and leptin resistance that leads to obesity and T2D.
Recent research has revealed that SOCS3 is a common inhibitor for leptin and insulin signaling . Indeed, forced overexpression of SOCS3 decreases both leptin-induced phosphorylation of JAK2 and insulin-induced phosphorylation of IR, IRS, and Akt. Selectively ablating the SOCS3 gene in hypothalamic neurons can enhance hypothalamic leptin signaling, which is sufficient to protect against dietary obesity (Howard et al., 2004; Kievit et al., 2006) . In this study, we find that the pathogenic induction of hypothalamic SOCS3 during overnutrition also requires NF-kB. More important, suppression of IKKb/NF-kB weakens the promotion of SOCS3 expression by various in vitro and in vivo conditions known to desensitize We propose that IKKb/NF-kB connects with ER stress in the hypothalamus and translates overnutrition into central insulin and leptin resistance, leading to the development of obesity and T2D (solid arrows). We also further postulate that, as obesity and T2D progress, IKKb/NF-kB participates in cumulative feedback loops (broken arrows).
insulin and leptin signaling. While other mechanisms remain to be explored, SOCS3 is an essential mediator for the pathological actions of hypothalamic IKKb/NF-kB in causing central leptin and insulin resistance that underlie obesity and T2D.
Hypothalamic IKKb as a Potential Target to Counter Obesity and T2D Our work also marks an initial attempt to study whether inhibiting an innate immune pathway in the hypothalamus could help to calibrate the set point of nutritional balance and therefore aid in counteracting energy imbalance and diseases induced by overnutrition. These results reveal that dietary obesity can be largely prevented by inhibiting IKKb/NF-kB either virally or genetically, whether broadly throughout the CNS, locally in the related hypothalamic regions, or precisely in a defined subpopulation of hypothalamic neurons. Altogether, our results suggest a novel therapeutic strategy for combating the ever-increasing spread of obesity and associated diseases. We recognize that the significance of this strategy has yet to be realized in clinical practice; currently, most anti-inflammatory therapies have limited direct effects on IKKb/NF-kB and limited capacity to be concentrated in the CNS. Nonetheless, our discoveries offer potential for treating these serious diseases. Because we also revealed that IKKb/ NF-kB normally remains inactive in the CNS, suppressing IKKb/ NF-kB in the hypothalamus is likely a safe approach. However, challenges still remain, such as finding methods to selectively suppress this pathway in the CNS, that will certainly inspire future research.
EXPERIMENTAL PROCEDURES
Animal Models and Chemicals NGL mice (Everhart et al., 2006) , IKKb lox/lox mice (Arkan et al., 2005) , and AGRP-Cre mice (Xu et al., 2005) have been described previously. Nestin-Cre mice, ob +/+ mice, db +/+ mice, and C57BL/6 mice were obtained from Jackson Laboratory. All the mouse lines were in C57BL/6, except for AGRP-Cre mice, which were originally in the FVB background. We backcrossed AGRP-Cre mice to C57BL/6 background for five generations. We identified and excluded a small fraction of whole-body IKKb knockout offspring from breeding AGRPCre mice with IKKb lox/lox mice. These mice were identified by using a PCR method to detect the excised IKKb gene in the genomes isolated from various peripheral and brain tissues. The UW-Madison IACUC approved the procedures. The HFD and normal chow were from Research Diets, Inc. and Harlan Teklad. TUDCA and TM were from Calbiochem, insulin was from Novartis, and leptin from R & D Systems.
Third-Ventricle and Intrahypothalamic Injections
The bilateral injections to the MBH were directed using an ultra-precise stereotax (Kopf Instruments) to the coordinates of 1.5 mm posterior to the bregma, 5.8 mm below the surface of the skull, and 0.4 mm lateral to midline. Purified lentivirus or adenovirus in artificial cerebrospinal fluid (aCSF) was injected over 10 min through a 26-gauge guide cannula and a 33-gauge injector connected to a Hamilton Syringe and an infusion pump. At the end of the experiments, the mice were assessed for intra-MBH deliveries by immunostaining the markers and the targets. Our final analyses included only those animals in which target induction was limited to the MBH and in which more than 70% of the targeted MBH cells were infected ( Figures S1B and S1C ). For third-ventricle cannulation, we implanted a guide cannula into the ventral third ventricle at the midline coordinates of 1.8 mm posterior to the bregma and 5.0 mm below the surface of the skull.
Acute Food Intake Studies and GTT
The individually housed mice were first measured for food intake induced by fasting. Four hours before the designated ''night time,'' we removed food and injected 1-2 ml of the vehicle (aCSF) into the third ventricle of each mouse. Food was then returned to the mice immediately before the designated ''night time.'' Food intake for each mouse was measured during the various following periods. This procedure was subsequently performed for the same set of mice but using instead an injection of insulin (5-10 mU) or leptin (5-15 mg). For GTT, overnight-fasted mice were IP injected with glucose (2 g/kg body weight). Blood glucose at various time points was measured using a Glucometer Elite (Bayer).
Plasmids and Recombinant Viruses
We introduced the cDNA of IKKb CA (S177/181E), IKKb DN (either S177/181A or K44A), or SOCS3 (provided by J. Seufert) into the lentiviral vector Lox-Syn-Syn (provided by G. Francisco) in which the synapsin promoter controlled neuronspecific expression of the introduced genes. The lentiviruses were produced from HEK293T cells through cotransfecting the target plasmid with package plasmids using CaCl 2 . Lentiviruses were purified by ultracentrifugation and then quantitated. Ad5-CMV-driven Cre adenovirus was provided by S. Albelda. Ad5-CMV-driven IKKb adenovirus and Ad5-CMV-driven GFP or LacZ were produced in our lab or in a core facility at UW-Madison.
Tissue Harvest, Immunoprecipitation, and Western Blots The hypothalamus was dissected according to the established method (Kim et al., 2006 ) ( Figure S1A ). Animal tissues were homogenized, and the proteins were dissolved in a lysis buffer, and western blots were performed as previously described (Cai et al., 2004 (Cai et al., , 2005 . Proteins dissolved in a lysis buffer or isolated by immunoprecipitation were separated by SDS-PAGE and identified by immunoblotting. Primary antibodies included rabbit anti-p-STAT3, anti-STAT3, anti-p85, anti-p-Akt, anti-Akt, anti-IKKb, anti-IKKa, anti-eIF2a, anti-p-eIF2a, anti-p-ERK, and anti-b-Actin (Cell Signaling); rabbit anti-IkBa, anti-PERK, anti-GFP, and anti-tubulin (Santa Cruz). Secondary antibodies included HRP-conjugated anti-rabbit and anti-mouse antibodies (Pierce).
Quantitative RT-PCR and EMSA We extracted total RNA from homogenized tissues using TRIzol (Invitrogen), synthesized cDNA using the Advantage RT for PCR kit (BD Biosciences), and performed real-time PCR using SYBRGreen PCR Master Mix (Applied Biosystems). Results were normalized against TATA box-binding protein (TBP) or GAPDH gene expression. We performed EMSA using the protocol detailed in our previous publications (Cai et al., 2004 (Cai et al., , 2005 . Briefly, NF-kB oligonucleotide (Santa Cruz) and two control oligonucleotides, Sp1 and Oct1 (Promega), were labeled with [g-32 P] ATP. The animal tissues were homogenized in a lysis buffer, and the lysate was then incubated with the probe. For negative controls, we used both mutant NF-kB gel-shift oligonucleotide (Santa Cruz) and cold competition with 200-fold excess of unlabeled NF-kB gel-shift oligonucleotide. The NF-kB-probe complex was separated in undenatured 4% PAGE, and the radioactivity was then detected on X-ray film.
Heart Perfusion, Immunostaining, and In Situ Hybridization Mice under anesthesia were transcardially perfused with 4% PFA, and the brains were removed, post-fixed in 4% PFA, and infiltrated with 20%-30% sucrose. Brain sections across the MBH (15 mm thickness) were blocked with serum of appropriate species, penetrated with 0.2% Triton X-100, treated with anti-Flag (Stratagene), anti-IKKb (Santa Cruz), anti-NeuN (Chemicon), anti-GFAP (Dako), anti-pSTAT3 (Cell Signaling), anti-PIP3 (Echelon), anti-SOCS3 (IBL), or anti-AGRP (Phoenix Pharmaceutical Inc) antibodies, and then subjected to reaction with fluorescence-conjugated secondary antibodies (Jackson). Naive IgGs of the appropriate species were used as negative controls. For in situ hybridization, free-floating slices were digested with proteinase K, prehybridized, and then hybridized with digoxigenin-labeled antisense IKKb nucleotide probe, and followed by color development using anti-digoxigenin antibody (Fab) conjugated with alkaline phosphatase (Roche) and NBT/BCIP substrates.
Statistical Analyses
Data are presented as mean ± SEM. Student's t tests were used for statistical analysis. p < 0.05 was considered significant.
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